Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Oncology|August 30, 2014
Final safety and efficacy analysis of a phase I/II trial with imatinib and vinorelbine for patients with metastatic breast cancerNicolai Maass, Christian Schem, Dirk O Bauerschlag, et al.
International Journal of Cancer|March 6, 2024
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO studyDiana Lüftner, Florian Schuetz, Andreas Schneeweiss, et al.
Journal of Bone Oncology|December 6, 2018
The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trialPeyman Hadji, Oliver Stoetzer, Thomas Decker, et al.
Breast Cancer Research and Treatment|July 13, 2010
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trialIsabell Witzel, Sibylle Loibl, Gunter von Minckwitz, et al.
International Journal of Cancer|July 12, 2018
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trialHans Tesch, Oliver Stoetzer, Thomas Decker, et al.
Breast (Edinburgh, Scotland)|September 10, 2023
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)Thomas Decker, Kerstin Lüdtke-Heckenkamp, Luidmila Melnichuk, et al.
Breast Cancer Research : BCR|December 11, 2012
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort studyKerstin Rhiem, Christoph Engel, Monika Graeser, et al.
Cancers|March 6, 2021
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic ScoresKerstin Riecke, Volkmar Müller, Rudolf Weide, et al.
Journal of Cancer Research and Clinical Oncology|September 28, 2013
Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR studyNicolai Maass, Nadia Harbeck, Christoph Mundhenke, et al.
Plos One|October 12, 2012
Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancerAntonia Sophie Wenners, Keyur Mehta, Sibylle Loibl, et al.
Pageof 9